Given widespread activating mutations in BRAF and, in particular, inability of Spry2 to attenuate ERK in the context of BRAFV600E mutation, their findings argue for a role of Sprouty in regulation of melanoma aggressiveness independent of attenuation of ERK. The gene discussed is BRAF; the disease is melanoma.